MahranShoukierMD

PubMed

• Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service.
  Joanna-Grace M Manzano, Hadeel Sahar, Jeffrey Aldrich, Maggie Lu, Mahran Shoukier, Christine B Peterson, Kodwo Dickson, Kwame Koom-Dadzie, Ed Kheder, Maria C Franco Ve...> ;Supportive Care in Cancer. 2024 Feb 16
• Industry's role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials.
  Tahsin Anwar, Sean Malhotra, Mohammad A H Mian, Tahiya Anwar, Vamsi Kota, Mahran Shoukier> ;Hematology. 2023 Dec 1
• 2 citations
  Representation of the population in need for pivotal clinical trials in lymphomas.
  Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, K M Islam, Jorge Cortes> ;Blood. 2023 Aug 31
• 2 citations
  A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.
  Nagla Abdel Karim, Asad Ullah, Hongkun Wang, Mahran Shoukier, Steven Pulliam, Ahmed Khaled, Nikhil Patel, John C Morris> ;Current Oncology. 2022 Dec 3
• 5 citations
  Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?
  Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, Jamani Garner, K M Islam, Jorge E Cortes> ;Journal of Clinical Oncology. 2022 Nov 10
• 9 citations
  Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.
  Jayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, Xuemei Wang, Keyur Patel, Tapan Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian, Naval Daver, Courtne...> ;American Journal of Hematology. 2022 May 1
• 1 citations
  Sudden Blast Crisis After Excellent Initial Response in Chronic Myeloid Leukemia.
  Aviraag Vijaya Prakash, Natasha M. Savage, Vamsi Kota, Mahran Shoukier, Keerthana P Sivakolundu> ;Cureus. 2021 Sep 28
• 38 citations
  Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy
  Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, Courtney D. DiNardo, Farhad Ravandi, Nicholas J. Short, Michael Andreeff, Gautam Borthakur, Naval Daver, Naveen...> ;Cancer. 2021 Oct 1
• 11 citations
  Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
  Mahran Shoukier, Michal Kubiak, Jorge E. Cortes> ;Current Oncology Reports. 2021 Jun 14
• 14 citations
  Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who re...
  Chantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, Hind Rafei, Jacinth Joseph, Gabriela Rondon, Laura K. Whited, Stephen K. Gruschkus, Faisal Fa’ak, May Daher, Cristin...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
• 9 citations
  Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations
  Mahran Shoukier, Tapan M. Kadia, Marina Konopleva, Ahmad S. Alotaibi, Mansour Alfayez, Sanam Loghavi, Keyur P. Patel, Rashmi Kanagal-Shamanna, Jorge E. Cortes, Bachar ...> ;Cancer. 2021 Feb 1
• 49 citations
  Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors
  Jeffrey Aldrich, Xerxes Pundole, Sudhakar Tummala, Nicolas Palaskas, Clark R. Andersen, Mahran Shoukier, Noha Abdel-Wahab, Anita Deswal, Maria E. Suarez-Almazor> ;Arthritis & Rheumatology. 2021 Mar 7
• 9 citations
  The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis
  Mahran Shoukier, Gautam Borthakur, Elias Jabbour, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Jairo Matthews, Lucia Masarova, Kiran Naqvi, Koji Sasaki, Sr...> ;Haematologica. 2020 Sep 14
• 8 citations
  The clinical impact of time to response in de novo accelerated-phase chronic myeloid leukemia
  Maro Ohanian, Hagop M. Kantarjian, Mahran Shoukier, Sara Dellasala, Arine Musaelyan, Graciela M. Nogueras González, Elias Jabbour, Lynne V. Abruzzo, Srdan Verstovsek, ...> ;American Journal of Hematology. 2020 Jun 17
• 8 citations
  Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study.
  Syed H Jafri, Faisal Ali, Arash Mollaeian, Syed Mojiz Hasan, Rahat Hussain, Bindu Akkanti, Jessica T. Williams, Mahran Shoukier, Hazem Edmond El-Osta> ;Clinical Medicine Insights. Oncology. 2019 May 1
• 13 citations
  Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study.
  Asifa Malik, Mahran Shoukier, Guillermo Garcia-Manero, William G. Wierda, Jorge E. Cortes, Susan Bickel, Michael J. Keating, Zeev Estrov> ;Clinical Lymphoma, Myeloma & Leukemia. 2013 Jun 1
• Join now to see all

Lectures

• The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis. 
  2019 ASCO Annual Meeting - 6/1/2019
• Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia. 
  2019 ASCO Annual Meeting - 6/1/2019